Work

Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy

Year: 2025

Type: other

Abstract: Ferroptosis is associated with favorable treatment outcomes in patients receiving immunotherapy. A, The flow chart shows the design of the study. B, OS analysis of patients based on ferroptosis levels in tumor tissue in the IMvigor210 cohort (urothelial cancers). C, OS analysis of patients based on ferroptosis levels in tumor tissue in the Snyder cohort (melanoma). D, OS analysis of patients based on ferroptosis levels in tumor tissue in the Liu cohort (melanoma). E, OS analysis of patients based on ferroptosis levels in tumor tissue in the Lauss cohort (melanoma). The log-rank test was applied for the survival analysis. GSEA, gene set enrichment analysis.

DOI: 10.1158/2767-9764.29836681

Authors: Zhijun Zhou, Yang Cai, Hao Yuan, Qun Chen, Sophia W. Zhao, Jingxuan Yang, Mingyang Liu, Alex X. Arreola, Yu Ren, Chao Xu, Lacey R. McNally, Michael S. Bronze, Courtney W. Houchen, Kuirong Jiang, Wei R. Chen, Yuqing Zhang, Min Li

Language: English

Topic: Ferroptosis and cancer prognosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4413023349

Cites:

Cited by:

Related to: 10